Solid Biosciences
SLDB
SLDB
75 hedge funds and large institutions have $414M invested in Solid Biosciences in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
21% more funds holding
Funds holding: 62 → 75 (+13)
0.56% more ownership
Funds ownership: 3.73% → 4.29% (+0.56%)
Holders
75
Holding in Top 10
2
Calls
$5.24M
Puts
$1.53M
Top Buyers
| 1 | +$60.5M | |
| 2 | +$41M | |
| 3 | +$30.7M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$30.7M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$24.2M |
Top Sellers
| 1 | -$3.47M | |
| 2 | -$1.79M | |
| 3 | -$623K | |
| 4 |
D.E. Shaw & Co
New York
|
-$509K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$349K |